Bausch Health Companies (TSE:BHC) Stock Price Up 0.3% – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC)’s stock price was up 0.3% during trading on Thursday . The company traded as high as C$7.34 and last traded at C$7.20. Approximately 247,672 shares were traded during trading, a decline of 47% from the average daily volume of 465,746 shares. The stock had previously closed at C$7.18.

Bausch Health Companies Price Performance

The stock has a market capitalization of C$2.69 billion, a price-to-earnings ratio of -2.22, a P/E/G ratio of 0.21 and a beta of 0.94. The company has a fifty day simple moving average of C$7.55 and a 200 day simple moving average of C$8.26. The company has a debt-to-equity ratio of -1,009.96, a quick ratio of 0.58 and a current ratio of 1.32.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported C$1.08 earnings per share (EPS) for the quarter. The company had revenue of C$3.51 billion during the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%. Equities research analysts forecast that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.